Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Express Scripts
Merck
Baxter
Boehringer Ingelheim

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022244

See Plans and Pricing

« Back to Dashboard

NDA 022244 describes LUSEDRA, which is a drug marketed by Eisai Inc and is included in one NDA. There is one patent protecting this drug. Additional details are available on the LUSEDRA profile page.

The generic ingredient in LUSEDRA is fospropofol disodium. Additional details are available on the fospropofol disodium profile page.
Summary for 022244
Tradename:LUSEDRA
Applicant:Eisai Inc
Ingredient:fospropofol disodium
Patents:1
Generic Entry Opportunity Date for 022244
Generic Entry Date for 022244*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INTRAVENOUSStrength1050MG/30ML (35MG/ML)
Approval Date:Dec 12, 2008TE:RLD:No
Patent:  Start TrialPatent Expiration:Jul 1, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:SEDATIVE-HYPNOTIC AGENT INDICATED FOR MONITORED ANESTHESIA CARE (MAC) SEDATION

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Mallinckrodt
AstraZeneca
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.